What is the P/E ratio of Citurgia Biochemicals?

The latest standalone P/E ratio of Citurgia Biochemicals as of 01-Jan-1970 is 0.00.

What is the P/B ratio of Citurgia Biochemicals?

The latest standalone P/B ratio of Citurgia Biochemicals as of 01-Jan-1970 is -851.45.

What is the 52-week high and low of Citurgia Biochemicals?

The 52-week high of Citurgia Biochemicals is Rs. 158.95 and the 52-week low is Rs. 150.00.

Citurgia Biochemicals Ltd - Stock Valuation and Financial Performance

Name: Citurgia Biochemicals
Brand: Citurgia Biochemicals

BSE: 506373 | NSE: CITURGIBIO | Chemicals | Small Cap

Place order

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Citurgia Biochem

Based on:

Data

M-Cap below 100cr DeciZen not available

Citurgia Biochemicals stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

0.00

Market Cap:

2,089.8 Cr.

52-wk low:

150

52-wk high:

159

Is an attractive stock to invest in?

1. Is a good quality company?

Data is not available for this company.

2. Is undervalued or overvalued?

No data found

3. Is a good buy now?

No data found

10 Year X-Ray of Citurgia Biochem:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
ROCE % ⓘ	-22.6%	-26%	-29.6%	-27.2%	-23.1%	-22.4%	-19.4%	-39.7%	-38.8%	-67.2%	-
Value Creation Index ⓘ	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	0	0	0	0	0	0	0	0	0	0	0
Sales YoY Gr.	-	NA	NA	NA	NA	NA	NA	NA	NA	NA	-
Adj EPS ⓘ	-0.1	-0.1	-0.1	-0	-0	-0.2	-0.2	-0.2	-0.2	-0.2	-0
YoY Gr.	-	NA	NA	NA	NA	NA	NA	NA	NA	NA	-
BVPS (₹) ⓘ	-0.3	-0.3	-0.4	-0.4	-0.5	-2.6	-2.7	-2.9	-3.1	-3.3	-0.2
Adj Net Profit ⓘ	-0.8	-0.8	-0.7	-0.5	-0.6	-0.6	-0.4	-0.6	-0.4	-0.4	0
Cash Flow from Ops. ⓘ	0.1	0	-0.1	-0.5	-1.3	-0.2	-0.1	-0.2	0	-0.1	-
Debt/CF from Ops. ⓘ	39	-165.9	-58	-10.1	-4.9	-34	-57.4	-43.9	-227.9	-96.9	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	NA	NA	NA
Adj EPS ⓘ	NA	NA	NA	NA
BVPSⓘ	NA	NA	NA	NA
Share Price	-	-	-	-

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
Return on Equity % ⓘ	112.3	49.1	29.3	18.7	16.3	14.2	8.9	12.4	7.4	7.4	1.7
Op. Profit Mgn % ⓘ	0	0	0	0	0	0	0	0	0	0	NAN
Net Profit Mgn % ⓘ	0	0	0	0	0	0	0	0	0	0	-INF
Debt to Equity ⓘ	-1.2	-1	-0.9	-0.9	-1	-1	-0.9	-0.8	-0.8	-0.8	-
Working Cap Days ⓘ	0	0	0	0	0	0	0	0	0	0	0
Cash Conv. Cycle ⓘ	0	0	0	0	0	0	0	0	0	0	0

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials - Citurgia Biochemicals Ltd.

	Standalone	Consolidated
TTM EPS (₹)	-0	-1.4
TTM Sales (₹ Cr.)	0	45
BVPS (₹.) ⓘ	-0.2	1.7
Reserves (₹ Cr.) ⓘ	-29	-4
P/BV ⓘ	-851.45	93.74
PE ⓘ	0.00	0.00

From the Market
52 Week Low / High (₹)	150.00 / 158.95
All Time Low / High (₹)	1.17 / 90.66
Market Cap (₹ Cr.)	2,090
Equity (₹ Cr.)	26.4
Face Value (₹)	2
Industry PE ⓘ	49.4

Management X-Ray of Citurgia Biochem:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Citurgia Biochem

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Citurgia Biochem

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Sales	0	0	0	0	0	0	0	0	0	0
Operating Expenses ⓘ	0.17	0.18	0.16	0.10	0.18	0.24	0.12	0.37	0.18	0.21
Manufacturing Costs	0	0	0	0	0	0	0	0	0	0
Material Costs	0	0	0	0	0	0	0	0	0	0
Employee Cost	0.05	0.04	0.05	0.03	0.04	0.13	0.10	0.14	0.16	0.16
Other Costs ⓘ	0.12	0.14	0.11	0.07	0.14	0.11	0.02	0.24	0.02	0.05
Operating Profit ⓘ	-0.17	-0.18	-0.16	-0.10	-0.18	-0.24	-0.12	-0.37	-0.18	-0.21
Operating Profit Margin (%)	-	-	-	-	-	-	-	-	-	-
Other Income ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	0	0	0	0	0	0	0	0	0	0
Depreciation ⓘ	0.67	0.58	0.50	0.43	0.37	0.32	0.28	0.24	0.23	0.23
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	-0.84	-0.76	-0.66	-0.54	-0.55	-0.56	-0.40	-0.61	-0.40	-0.44
Tax ⓘ	0	0	0	0	0	0	0	0	0	0
Profit After Tax	-0.84	-0.76	-0.66	-0.54	-0.55	-0.56	-0.40	-0.61	-0.40	-0.44
PAT Margin (%)	-	-	-	-	-	-	-	-	-	-
Adjusted EPS (₹)	-0.1	-0.1	-0.1	0.0	0.0	-0.2	-0.2	-0.2	-0.2	-0.2
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Equity and Liabilities
Shareholders Fund	-3.67	-4.43	-5.09	-5.63	-6.18	-6.74	-7.14	-7.75	-8.16	-8.59
Share Capital ⓘ	26.42	26.42	26.42	26.42	26.42	26.42	26.42	26.42	26.42	26.42
Reserves ⓘ	-30.09	-30.85	-31.51	-32.05	-32.60	-33.16	-33.56	-34.17	-34.58	-35.01
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	4.47	4.49	4.50	5.15	6.45	6.48	6.48	6.50	6.50	6.55
Long Term Debt	4.44	4.46	4.47	5.12	6.42	6.45	6.45	6.46	6.46	6.52
Short Term Debt	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03
Trade Payables	3.82	3.63	3.63	3.63	3.63	3.63	3.63	3.63	3.63	3.63
Others Liabilities ⓘ	6.60	7.46	8.54	8.79	8.91	8.99	9	9.22	9.46	9.60
Total Liabilities ⓘ	11.22	11.15	11.58	11.95	12.82	12.36	11.97	11.60	11.43	11.19
Fixed Assets
Gross Block	6.42	6.42	6.42	6.42	6.42	2.04	6.42	6.43	6.42	6.42
Accumulated Depreciation	2.18	2.76	3.26	3.69	4.07	0	4.66	4.90	5.13	5.35
Net Fixed Assetsⓘ	4.24	3.66	3.16	2.73	2.36	2.04	1.76	1.52	1.30	1.07
CWIP ⓘ	0	0	0	0	0	0	0	0	0	0
Investmentsⓘ	0	0	0	0	0	0	0	0	0	0
Inventories	4.63	5.17	6.12	6.78	8.04	8.07	8.07	8.07	8.07	8.07
Trade Receivables	0	0	0	0	0	0	0	0	0	0
Cash Equivalents	0.18	0.15	0.08	0.35	0.26	0.11	0.06	0.07	0.05	0.08
Others Assetsⓘ	2.16	2.16	2.22	2.09	2.16	2.14	2.09	1.94	2.01	1.97
Total Assets ⓘ	11.22	11.15	11.58	11.95	12.82	12.36	11.97	11.60	11.43	11.19

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Cash Flow From Operating Activity ⓘ	0.11	-0.03	-0.08	-0.51	-1.32	-0.19	-0.11	-0.15	-0.03	-0.07
PBT ⓘ	-0.84	-0.76	-0.66	-0.54	-0.55	-0.56	-0.40	-0.61	-0.40	-0.44
Adjustment ⓘ	0.67	0.58	0.50	0.43	0.37	0.32	0.28	0.24	0.23	0.23
Changes in Working Capital ⓘ	0.28	0.15	0.08	-0.41	-1.14	0.05	0.01	0.23	0.15	0.14
Tax Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Cash Flow From Investing Activity ⓘ	0	0	0	0.13	-0.07	0.02	0.06	0.15	0.01	0.04
Capex	0	0	0	0	0	0	0	0	0	0
Net Investments	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	0	0	0.13	-0.07	0.02	0.06	0.15	0.01	0.04
Cash Flow From Financing Activityⓘ	0	0	0	0.65	1.30	0.03	0	0.01	0	0.06
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0.65	1.30	0.03	0	0.01	0	0.06
Interest Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	0	0	0	0	0	0	0	0	0
Net Cash Flow ⓘ	0.11	-0.03	-0.08	0.27	-0.09	-0.15	-0.06	0.01	-0.01	0.02

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Ratios
ROE (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
ROCE (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Asset Turnover Ratio	0	0	0	0	0	0	0	0	0	0
PAT to CFO Conversion(x)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Days
Receivable Days	0	0	0	0	0	0	0	0	0	0
Inventory Days	0	0	0	0	0	0	0	0	0	0
Payable Days	0	0	0	0	0	0	0	0	0	0

Citurgia Biochemicals Ltd Stock News

Citurgia Biochemicals Ltd FAQs

What is the share price of Citurgia Biochem?

Company share prices are keep on changing according to the market conditions. The closing price of Citurgia Biochem on 01-Jan-1970 05:30 is ₹0.00.

What is the market cap of Citurgia Biochem?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Citurgia Biochem stood at ₹2,089.8.

What is the P/E ratio of Citurgia Biochem?

The latest P/E ratio of Citurgia Biochem as of 01-Jan-1970 05:30 is 0.00.

What is the P/B ratio of Citurgia Biochem?

The latest P/B ratio of Citurgia Biochem as of 01-Jan-1970 05:30 is -851.45.

What is the 52-week high and low of Citurgia Biochem?

The 52-week high of Citurgia Biochem is ₹158.9 and the 52-week low is ₹150.0.

What is the TTM revenue of Citurgia Biochem?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Citurgia Biochem is ₹0.00 ( Cr.) .

About Citurgia Biochemicals Ltd

Citurgia Biochemicals was incorporated in 1974 in Mumbai. The company manufactures citric acid, calcium carbonate and plasticizers. Citric acid is traditionally used in foods, soft drinks, confectionery and drugs. It is also used in textile printing and dyeing, where it provides stable pH conditions for polyester and nylon, acrylic print-curing and cotton-resist printing.

The company was promoted by John and E. Sturdia, UK; Bombay Dyeing and Manufacturing Company; and Sturdia Chemical. In 1987-1988, it acquired two subsidiaries, Sodality Trading and Agencies and Himgiri Trading and Agencies. The company exports citric acid to US, Japan, Germany, Australia, Iran, Malaysia and Sri Lanka.

Milestones:

1974 - The company was incorporated on 13th September at Mumbai. It manufactures Citric Acid, Calcium Carbonate and Plasticizers. The company was promoted by John and E Sturdia, U.K. The Bombay Dyeing and Manufacturing Company, and Sturdia Chemicals, Mumbai. - The company entered into a technical collaboration with the company John and E. Sturge, in U.K. for manufacture of citric acid. - Towards the payment of imported plant and equipment, the company was to allot to the collaborators 11,00,000 equity shares of Rs 10 each. The collaborators were to supply the technical know-how for the manufacture of citric acid. - 10,001 shares subscribed for by the signatories to the Memorandum of Association; 10,44,317 shares allotted without payment in cash to John and E. Sturge, U.K; 1,49,500 shares allotted to The Bombay Dyeing and Mfg. Co.; 79,000 allotted to Chemicals, and 2,12,999 shares allotted to directors and shareholders of Sturdia Chemicals.
1978 - 15,04,183 shares issued at par through a prospectus dated 10.1.1997; 55,683 shares reserved for allotment to John and E. Sturge, U.K. without payment in cash. 1,48,500 shares reserved to The Bombay Dyeing and Mfg. Co. and 13,00,000shares offered for public subscription during February 1977.
1983 - Jasper Investment, a wholly owned subsidiary of Sturdia chemicals became subsidiary of the company on Sturdia's amalgamation with the company. - With effect from 1st April, Sturdia Chemicals was amalgamated with the Company. As per the scheme of amalgamation, the company issued 3 equity shares of Rs 10 each for every two equity shares held in Sturdia Chemicals (SCL), by the erstwhile shareholders of SCL. Totally 22,50,000 equity shares of the company were allotted to the erstwhile shareholders of Sturdia Chemicals as on 2nd November, 1984.
1984 - 22,50,000 No. of equity shares issued without payment in cash to the members of Sturdia Chemicals, on its merger with the Company.
1985 - The working was adversely affected due to lock-out at the Surat plant from 30th December. The lock out at the Surat plant was lifted on May 15, 1986. - It was proposed to expand the installed capacity of citric acid from 5,000 tonnes to 8,000 tonnes per annum. Efforts were also being made for further modernisation of the Hrishikesh plant by installation of new equipment and instrumentation.
1987 - The Company successfully commissioned the anaerobic effluents discharged in the process of manufacturing citric acid at the Surat plant. - 18,68,735 No. of equity shares cancelled as per the scheme of reduction of capital.
1988 - The company issued 2,00,000-14% secured non-convertible debentures of Rs 100 each on private placement basis. These are redeemable at a premium of Rs 5 per debenture in 1995-96.
1989 - The Company privately placed with Army Group Insurance Directorate 1,15,000-14% secured non-convertible debentures of Rs 100 each. These are redeemable at premium of 5% in 1997.
1990 - The Company issued 4,95,000-14% secured non-convertible debentures of Rs 100 each. These are redeemable at a premium of Rs 5 per debenture in three equal annual installments from 1996-97.
1991 - The Company successfully commissioned a 10 MT/hr fuel efficient oil-fired boiler at the Rishikesh plant
1992 - The Company with a view to improve the yield and productivity of the fermentation process proposed to examine a new recovery technology.
1994 - The Company under took to modernise and expand the calcium carbonate plant.
1995 - A more productive strain of citric acid fermenting organism to reduce usage of raw material was introduced. The Company evaluated various proposals for debottlenecking plant capacity. - The Company received a sum of Rs 500.0 lakhs from ICICI sanctioned in participation with other financial institutions towards modernisation of its citric acid plant at Surat.
2002 - H C Pandya ceases to hold office of Director in Citurgia Biochemicals.

Business areas of the company:

Citurgia Biochemicals engages in the manufacture, sale, and export of calcium carbonate in India. The company is based in Mumbai, India. The company has expressed its full support for fixation of anti-dumping.